Skip to main content
Erschienen in: Medical Oncology 4/2020

01.04.2020 | Original Paper

Identification of pancreatic cancer type related factors by Weighted Gene Co-Expression Network Analysis

verfasst von: Wei Wang, Haibo Xing, Changxin Huang, Hong Pan, Da Li

Erschienen in: Medical Oncology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

This study aims to identify the core modules associated with pancreatic cancer (PC) types and the ncRNAs and transcription factors (TFs) that regulate core module genes by weighted gene co-expression network analysis (WGCNA). WGCNA was used to analyze the union of genes related to PC in NCBI and OMIM databases and the differentially expressed genes screened by TCGA-PAAD database. Samples were clustered according to gene expression in gene modules and Fisher exact method was performed. GO and KEGG were used for enrichment analysis to visually display module genes and screen driver genes. Hypergeometric test method was used to calculate pivot nodes among ncRNAs, TFs and mRNA based on RAID 2.0 and TRRUST v2 databases. The blue and yellow modules were identified as the core modules associated with PC types. MST1R, TMPRSS, MIR198, SULF1, COL1A1 and FAP were the core genes in the modules. Hypergeometric test results showed that ANCR, miR-3134, MT1DP, LOC154449, LOC28329 and other ncRNAs were key factors driving blue module genes, while LINC-ROR, UCA1, SNORD114-4, HEIH, SNORD114-6 and other ncRNAs were key factors driving yellow module genes. TFs with significant regulatory effect on blue module included LCOR, PIAS4, ZEB1, SNAI2, SMARCA4, etc. and on yellow module included HOXC6, PER2, HOXD3, TWIST2, VHL, etc. The core modules associated with PC types were proved as yellow and blue modules, and important ncRNAs and TFs regulating yellow and blue modules were found. This study provides relevant evidence for further identification of PC types.
Literatur
1.
Zurück zum Zitat Giannuzzo A, Pedersen SF, Novak I. The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells. Mol Cancer. 2015;14:203.CrossRef Giannuzzo A, Pedersen SF, Novak I. The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells. Mol Cancer. 2015;14:203.CrossRef
2.
Zurück zum Zitat Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016;22(44):9694–705.CrossRef Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016;22(44):9694–705.CrossRef
3.
Zurück zum Zitat Lou C, Zhang F, Yang M, et al. Naringenin decreases invasiveness and metastasis by inhibiting TGF-beta-induced epithelial to mesenchymal transition in pancreatic cancer cells. PLoS ONE. 2012;7(12):e50956.CrossRef Lou C, Zhang F, Yang M, et al. Naringenin decreases invasiveness and metastasis by inhibiting TGF-beta-induced epithelial to mesenchymal transition in pancreatic cancer cells. PLoS ONE. 2012;7(12):e50956.CrossRef
4.
Zurück zum Zitat Zhang QH, Ni QX. Clinical analysis of 2340 cases of pancreatic cancer. Zhonghua Yi Xue Za Zhi. 2004;84(3):214–8.PubMed Zhang QH, Ni QX. Clinical analysis of 2340 cases of pancreatic cancer. Zhonghua Yi Xue Za Zhi. 2004;84(3):214–8.PubMed
5.
Zurück zum Zitat Lin QJ, Yang F, Jin C, et al. Current status and progress of pancreatic cancer in China. World J Gastroenterol. 2015;21(26):7988–8003.CrossRef Lin QJ, Yang F, Jin C, et al. Current status and progress of pancreatic cancer in China. World J Gastroenterol. 2015;21(26):7988–8003.CrossRef
6.
Zurück zum Zitat Rosenberg A, Mahalingam D. Immunotherapy in pancreatic adenocarcinoma-overcoming barriers to response. J Gastrointest Oncol. 2018;9(1):143–59.CrossRef Rosenberg A, Mahalingam D. Immunotherapy in pancreatic adenocarcinoma-overcoming barriers to response. J Gastrointest Oncol. 2018;9(1):143–59.CrossRef
7.
Zurück zum Zitat Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005;4:17.CrossRef Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005;4:17.CrossRef
8.
Zurück zum Zitat Schafer ST, Paquola ACM, Stern S, et al. Pathological priming causes developmental gene network heterochronicity in autistic subject-derived neurons. Nat Neurosci. 2019;22(2):243–55.CrossRef Schafer ST, Paquola ACM, Stern S, et al. Pathological priming causes developmental gene network heterochronicity in autistic subject-derived neurons. Nat Neurosci. 2019;22(2):243–55.CrossRef
9.
Zurück zum Zitat Zhou Z, Cheng Y, Jiang Y, et al. Ten hub genes associated with progression and prognosis of pancreatic carcinoma identified by co-expression analysis. Int J Biol Sci. 2018;14(2):124–36.CrossRef Zhou Z, Cheng Y, Jiang Y, et al. Ten hub genes associated with progression and prognosis of pancreatic carcinoma identified by co-expression analysis. Int J Biol Sci. 2018;14(2):124–36.CrossRef
10.
Zurück zum Zitat Yin L, Cai Z, Zhu B, et al. Identification of key pathways and genes in the dynamic progression of HCC based on WGCNA. Genes. 2018;9(2):92.CrossRef Yin L, Cai Z, Zhu B, et al. Identification of key pathways and genes in the dynamic progression of HCC based on WGCNA. Genes. 2018;9(2):92.CrossRef
11.
Zurück zum Zitat Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47–e4747.CrossRef Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47–e4747.CrossRef
12.
Zurück zum Zitat Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.CrossRef Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.CrossRef
13.
Zurück zum Zitat Liu W, Xu P, Bao Z. Understanding the mechanisms of cancers based on function sub-pathways. Comput Biol Chem. 2019;78:491–6.CrossRef Liu W, Xu P, Bao Z. Understanding the mechanisms of cancers based on function sub-pathways. Comput Biol Chem. 2019;78:491–6.CrossRef
14.
Zurück zum Zitat He Z, Sun M, Ke Y, et al. Identifying biomarkers of papillary renal cell carcinoma associated with pathological stage by weighted gene co-expression network analysis. Oncotarget. 2017;8(17):27904–14.PubMedPubMedCentral He Z, Sun M, Ke Y, et al. Identifying biomarkers of papillary renal cell carcinoma associated with pathological stage by weighted gene co-expression network analysis. Oncotarget. 2017;8(17):27904–14.PubMedPubMedCentral
15.
Zurück zum Zitat Chen P, Wang F, Feng J, et al. Co-expression network analysis identified six hub genes in association with metastasis risk and prognosis in hepatocellular carcinoma. Oncotarget. 2017;8(30):48948–58.PubMedPubMedCentral Chen P, Wang F, Feng J, et al. Co-expression network analysis identified six hub genes in association with metastasis risk and prognosis in hepatocellular carcinoma. Oncotarget. 2017;8(30):48948–58.PubMedPubMedCentral
16.
Zurück zum Zitat Huang J, Li Y, Lu Z, et al. Analysis of functional hub genes identifies CDC45 as an oncogene in non-small cell lung cancer—a short report. Cell Oncol. 2019;42(4):571–8.CrossRef Huang J, Li Y, Lu Z, et al. Analysis of functional hub genes identifies CDC45 as an oncogene in non-small cell lung cancer—a short report. Cell Oncol. 2019;42(4):571–8.CrossRef
17.
Zurück zum Zitat Iwama A, Yamaguchi N, Suda T. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family. Embo J. 1996;15(21):5866–75.CrossRef Iwama A, Yamaguchi N, Suda T. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family. Embo J. 1996;15(21):5866–75.CrossRef
18.
Zurück zum Zitat Peace BE, Hughes MJ, Degen SJ, et al. Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis. Oncogene. 2001;20(43):6142–51.CrossRef Peace BE, Hughes MJ, Degen SJ, et al. Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis. Oncogene. 2001;20(43):6142–51.CrossRef
19.
Zurück zum Zitat Wang MH, Wang D, Chen YQ. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase. Carcinogenesis. 2003;24(8):1291–300.CrossRef Wang MH, Wang D, Chen YQ. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase. Carcinogenesis. 2003;24(8):1291–300.CrossRef
20.
Zurück zum Zitat Camp ER, Liu W, Fan F, et al. RON, a tyrosine kinase receptor involved in tumor progression and metastasis. Ann Surg Oncol. 2005;12(4):273–81.CrossRef Camp ER, Liu W, Fan F, et al. RON, a tyrosine kinase receptor involved in tumor progression and metastasis. Ann Surg Oncol. 2005;12(4):273–81.CrossRef
21.
Zurück zum Zitat Goel HL, Li J, Kogan S, et al. Integrins in prostate cancer progression. Endocr Relat Cancer. 2008;15(3):657–64.CrossRef Goel HL, Li J, Kogan S, et al. Integrins in prostate cancer progression. Endocr Relat Cancer. 2008;15(3):657–64.CrossRef
22.
Zurück zum Zitat Liu J, Eischeid AN, Chen XM. Col1A1 production and apoptotic resistance in TGF-beta1-induced epithelial-to-mesenchymal transition-like phenotype of 603B cells. PLoS ONE. 2012;7(12):e51371.CrossRef Liu J, Eischeid AN, Chen XM. Col1A1 production and apoptotic resistance in TGF-beta1-induced epithelial-to-mesenchymal transition-like phenotype of 603B cells. PLoS ONE. 2012;7(12):e51371.CrossRef
23.
Zurück zum Zitat Hills CE, Squires PE. TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. Am J Nephrol. 2010;31(1):68–74.CrossRef Hills CE, Squires PE. TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. Am J Nephrol. 2010;31(1):68–74.CrossRef
24.
Zurück zum Zitat Saito D, Kyakumoto S, Chosa N, et al. Transforming growth factor-beta1 induces epithelial-mesenchymal transition and integrin alpha3beta1-mediated cell migration of HSC-4 human squamous cell carcinoma cells through Slug. J Biochem. 2013;153(3):303–15.CrossRef Saito D, Kyakumoto S, Chosa N, et al. Transforming growth factor-beta1 induces epithelial-mesenchymal transition and integrin alpha3beta1-mediated cell migration of HSC-4 human squamous cell carcinoma cells through Slug. J Biochem. 2013;153(3):303–15.CrossRef
25.
Zurück zum Zitat Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology. 2007;39(3):305–18.CrossRef Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology. 2007;39(3):305–18.CrossRef
26.
Zurück zum Zitat Ungefroren H, Kruse ML, Trauzold A, et al. FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis. J Cell Sci. 2001;114(Pt 15):2735–46.PubMed Ungefroren H, Kruse ML, Trauzold A, et al. FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis. J Cell Sci. 2001;114(Pt 15):2735–46.PubMed
27.
Zurück zum Zitat Gill RMS, Michael A, Westley L, et al. SULF1/SULF2 splice variants differentially regulate pancreatic tumour growth progression. Exp Cell Res. 2014;324(2):157–71.CrossRef Gill RMS, Michael A, Westley L, et al. SULF1/SULF2 splice variants differentially regulate pancreatic tumour growth progression. Exp Cell Res. 2014;324(2):157–71.CrossRef
28.
Zurück zum Zitat Marin-Muller C, Li D, Bharadwaj U, et al. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer. Clin Cancer Res. 2013;19(21):5901–13.CrossRef Marin-Muller C, Li D, Bharadwaj U, et al. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer. Clin Cancer Res. 2013;19(21):5901–13.CrossRef
29.
Zurück zum Zitat Pang EJ, Yang R, Fu XB, et al. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer. Tumour Biol. 2015;36(4):2403–7.CrossRef Pang EJ, Yang R, Fu XB, et al. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer. Tumour Biol. 2015;36(4):2403–7.CrossRef
30.
Zurück zum Zitat Sun YW, Chen YF, Li J, et al. A novel long non-coding RNA ENST00000480739 suppresses tumour cell invasion by regulating OS-9 and HIF-1alpha in pancreatic ductal adenocarcinoma. Br J Cancer. 2014;111(11):2131–41.CrossRef Sun YW, Chen YF, Li J, et al. A novel long non-coding RNA ENST00000480739 suppresses tumour cell invasion by regulating OS-9 and HIF-1alpha in pancreatic ductal adenocarcinoma. Br J Cancer. 2014;111(11):2131–41.CrossRef
31.
Zurück zum Zitat Chen P, Wan D, Zheng D, et al. Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer. Biomed Pharmacother. 2016;83:1220–6.CrossRef Chen P, Wan D, Zheng D, et al. Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer. Biomed Pharmacother. 2016;83:1220–6.CrossRef
32.
Zurück zum Zitat Li C, Zhao Z, Zhou Z, et al. Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis. Cancer Chemother Pharmacol. 2016;78(6):1199–207.CrossRef Li C, Zhao Z, Zhou Z, et al. Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis. Cancer Chemother Pharmacol. 2016;78(6):1199–207.CrossRef
33.
Zurück zum Zitat Todeschini AL, Georges A, Veitia RA. Transcription factors: specific DNA binding and specific gene regulation. Trends Genet. 2014;30(6):211–9.CrossRef Todeschini AL, Georges A, Veitia RA. Transcription factors: specific DNA binding and specific gene regulation. Trends Genet. 2014;30(6):211–9.CrossRef
34.
Zurück zum Zitat Wilkinson KA, Henley JM. Mechanisms, regulation and consequences of protein SUMOylation. Biochem J. 2010;428(2):133–45.CrossRef Wilkinson KA, Henley JM. Mechanisms, regulation and consequences of protein SUMOylation. Biochem J. 2010;428(2):133–45.CrossRef
35.
Zurück zum Zitat Gross M, Yang R, Top I, et al. PIASy-mediated repression of the androgen receptor is independent of sumoylation. Oncogene. 2004;23(17):3059–66.CrossRef Gross M, Yang R, Top I, et al. PIASy-mediated repression of the androgen receptor is independent of sumoylation. Oncogene. 2004;23(17):3059–66.CrossRef
36.
Zurück zum Zitat Bischof O, Schwamborn K, Martin N, et al. The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis. Mol Cell. 2006;22(6):783–94.CrossRef Bischof O, Schwamborn K, Martin N, et al. The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis. Mol Cell. 2006;22(6):783–94.CrossRef
37.
Zurück zum Zitat Chien W, Lee KL, Ding LW, et al. PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cells. Br J Cancer. 2013;109(7):1795–804.CrossRef Chien W, Lee KL, Ding LW, et al. PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cells. Br J Cancer. 2013;109(7):1795–804.CrossRef
38.
Zurück zum Zitat DeCoursey TE, Chandy KG, Gupta S, et al. Voltage-dependent ion channels in T-lymphocytes. J Neuroimmunol. 1985;10(1):71–95.CrossRef DeCoursey TE, Chandy KG, Gupta S, et al. Voltage-dependent ion channels in T-lymphocytes. J Neuroimmunol. 1985;10(1):71–95.CrossRef
39.
Zurück zum Zitat Miyazaki YJ, Hamada J, Tada M, et al. HOXD3 enhances motility and invasiveness through the TGF-beta-dependent and -independent pathways in A549 cells. Oncogene. 2002;21(5):798–808.CrossRef Miyazaki YJ, Hamada J, Tada M, et al. HOXD3 enhances motility and invasiveness through the TGF-beta-dependent and -independent pathways in A549 cells. Oncogene. 2002;21(5):798–808.CrossRef
Metadaten
Titel
Identification of pancreatic cancer type related factors by Weighted Gene Co-Expression Network Analysis
verfasst von
Wei Wang
Haibo Xing
Changxin Huang
Hong Pan
Da Li
Publikationsdatum
01.04.2020
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 4/2020
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-020-1339-0

Weitere Artikel der Ausgabe 4/2020

Medical Oncology 4/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.